^
BIOMARKER:

NF2 mutation

i
Other names: Nf2, Merlin
Entrez ID:
Related biomarkers:
NF2 mutation
Breast Cancer
bevacizumab
Sensitive: C3 – Early Trials
NF2 mutation
Thyroid Gland Anaplastic Carcinoma
atezolizumab + cobimetinib
Sensitive: C3 – Early Trials
NF2 mutation
Kidney Medullary Carcinoma
bevacizumab + erlotinib
Sensitive: C4 – Case Studies
NF2 mutation
Mesothelioma
CBL0102
Sensitive: D – Preclinical
Front Pharmacol - 4 weeks
NF2 mutation
Mesothelioma
verteporfin
Sensitive: D – Preclinical
Cancer Discov - 4 weeks